Sonia S. Kupfer, MD

Prevalence of Pathogenic Germline Variants in Patients With Gastric Cancer Ascertained Through Multigene Panel Testing.
Prevalence of Pathogenic Germline Variants in Patients With Gastric Cancer Ascertained Through Multigene Panel Testing. JCO Precis Oncol. 2025 Jun; 9:e2400620.
PMID: 40466029

Upper GI polyposis and cancer in FAP: diagnosis, surveillance and treatment.
Upper GI polyposis and cancer in FAP: diagnosis, surveillance and treatment. Fam Cancer. 2025 May 26; 24(2):49.
PMID: 40418521

Screening at the scope: enhancing the role of pathologists in diagnosing gastrointestinal polyposis syndromes.
Screening at the scope: enhancing the role of pathologists in diagnosing gastrointestinal polyposis syndromes. Virchows Arch. 2025 May 13.
PMID: 40358740

Advancing the Evaluation and Management of CDH1-Associated Gastric Cancer.
Advancing the Evaluation and Management of CDH1-Associated Gastric Cancer. J Natl Compr Canc Netw. 2025 04; 23(4).
PMID: 40203872

Genomic and cellular responses to aspirin in colonic organoids from African- and European-Americans.
Genomic and cellular responses to aspirin in colonic organoids from African- and European-Americans. Physiol Genomics. 2025 Mar 01; 57(3):103-114.
PMID: 39812338

Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2024 12; 22(10):695-711.
PMID: 39689429

Anticipation in families with MLH1-associated Lynch syndrome.
Anticipation in families with MLH1-associated Lynch syndrome. Cancer. 2025 Jan 01; 131(1):e35589.
PMID: 39435727

Germline CDH1 Variants and Lifetime Cancer Risk.
Germline CDH1 Variants and Lifetime Cancer Risk. JAMA. 2024 09 03; 332(9):722-729.
PMID: 38873722

Creation of a Quality Payment Program Measure for Mismatch Repair or Microsatellite Instability Biomarker Testing Status in Colorectal, Endometrial, Gastroesophageal, or Small Bowel Carcinoma.
Creation of a Quality Payment Program Measure for Mismatch Repair or Microsatellite Instability Biomarker Testing Status in Colorectal, Endometrial, Gastroesophageal, or Small Bowel Carcinoma. Arch Pathol Lab Med. 2024 Jun 01; 148(6):728-734.
PMID: 37708308

The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration.
The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration. Cancer. 2024 Oct 01; 130(19):3297-3304.
PMID: 38809542